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Most UK hospitals, laboratories, and research institutions use uniform reference intervals
(RI) that do not take into account known diurnal and racial variation in total white blood
cells (WBC) count and its constituent parameters. These risks of excluding potentially
suitable ethnic minority volunteers from participating in phase I clinical trials could call into
question the validity of a trial’s findings or limit its scientific applications and ability to
accurately observe drug effects upon WBC parameters. This study pools data from
multiple phase I trials, assesses the effects of race and time of day on WBC count, and
compares it to the existing literature to establish race and time-specific RIs. A total 13,332
venous blood samples obtained from 7,157 healthy male and female volunteers at the
time of screening or admission (predosing) who took part in 35 phase I trials over a period
of seven years were pooled and the data were analyzed using generalised estimating
equation models. Adjusted RI of total WBC count and its individual parameters were then
calculated according to time of day (morning vs. evening) for both black and nonblack
populations. This study indicates that black individuals on average had lower total WBC,
neutrophil, monocyte, eosinophil, and basophil counts than individuals from nonblack
racial groups. Black volunteers had higher mean lymphocyte counts relative to their
nonblack counterparts. These differences were deemed statistically significant.
Statistically significant increases in total WBC, neutrophil, lymphocyte, and monocyte
counts were also observed over the course of daily sampling. Eosinophil counts
decreased during this time period, but this finding was only statistically significant in the
nonblack population. Despite an observed mild diurnal increase in basophil count in both
populations, this was not considered statistically significant. This high-powered study
adds significant weight to the known evidence for diurnal and racial variation in WBC
parameters. Importantly, it proposes specific RIs that more precisely reflect race and time
of day. These could ensure increased participation of black volunteers in clinical trials for
improved population representation. Furthermore, the proposed RIs allow for morein.org March 2020 | Volume 11 | Article 3141
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postdose WBC count changes.Keywords: white blood cell, racial, diurnal, inclusion criteria, reference intervalsINTRODUCTION
Most UK hospitals, laboratories, CROs, and other research
institutions use uniform reference intervals (RI) for white blood
cell (WBC) parameters, irrespective of an individual’s race, gender,
age, or the time of day. However, as described below, genetic and
diurnal variation in WBC parameters is an acknowledged
phenomenon. Adopting a single reference range is thus
potentially unsuitable and could result in the underrepresentation
of volunteers from ethnic minority groups in early phase clinical
trials (Haley et al., 2017; Sheffet et al., 2018). Furthermore, a poor
representation of these groups in phase I studies may call into
question the validity of a clinical trial’s findings (Hussain-Gambles
et al., 2004), limit its scientific applications, and amplify health
disparities (Chen et al., 2014). Low participation rates in clinical
trials by historically underrepresented groups has previously
contributed to failures in detecting potential harm as population
representation proved insufficient to spot negative effects (Roberts
et al., 2012). A single reference range may also limit the ability to
accurately observe drug effects on WBC parameters.
A single WBC reference range does not take account of
genetically determined lower neutrophil counts reported in
subjects of African ancestry (Nalls et al., 2008; Reich et al.,
2009; Thobakgale and Ndung'u, 2014). These individuals have
lower neutrophil and total WBC counts and are at high risk of
being barred from participation in phase I studies. An absolute
neutrophil count (ANC) of 1.5 × 109 cells/liter is often deemed
the minimum threshold for an individual to be included in a
clinical trial. Individuals with a WBC <1.5 × 109 cells/liter that is
not secondary to any pathology and who are otherwise healthy
are deemed to have Benign Ethnic Neutropenia (BEN) (Hsieh
et al., 2005), yet are frequently excluded from trial participation.
BEN occurs in <1% of individuals of European ancestry (Hsieh,
2007), yet has a prevalence of up to 50% in individuals of African
descent (Haddy et al., 1999; Keller et al., 2014; Tandeter et al.,
2016; Rahmani et al., 2017) because of the near 100% prevalence
of the Duffy Antigen Receptor for Chemokines (DARC) allele
(rs2814778) found across sub-Saharan populations (McManus
et al., 2017) and associated with lower neutrophil counts (Hsieh
et al., 2007; Crosslin et al., 2012).
The scientific literature highlights that both total WBCs and
constituent cells (neutrophils, monocytes, lymphocytes,
basophils, eosinophils) vary across the diurnal cycle (Doan and
Zefas, 1927; McKee et al., 2011; Sennels et al., 2011; Ackermann
et al., 2012; Ella et al., 2016; Souto-Filho et al., 2019), with
neutrophils peaking in the evening and being at their lowest in
the morning (Sennels et al., 2011; Ella et al., 2016). Furthermore,
neutrophil and monocyte migration from blood to tissue showed
circadian oscillations that cause variations in the magnitude of
inflammatory responses (Scheiermann et al., 2012; Scheiermannin.org 2et al., 2013) and diurnal variation of lymphocyte trafficking
appears to be under adrenergic control (Suzuki et al., 2016).
This is a significant observation as blood samples are typically
obtained at various time points during a trial and there is a risk
that diurnal variation in WBC could be wrongly attributed to the
activity of an Investigational Medicinal Product (IMP)—defined
as “an active ingredient or placebo that has been pharmaceutically
formulated (prepared) for human use which is being tested, or
used as a comparator, in a clinical trial” (EUPATI, 2019).
Single RIs for each WBC parameter that fail to consider racial
and diurnal variation, arguably, lack validity and could result in
clinicians being misled about any potential drug effects and the
status of an individual’s immune system, resulting in their
inappropriate exclusion from a clinical trial. This study pools
WBC parameters from multiple phase I trials, assesses the effects
of race and time of day onWBC count, and compares these to the
existing literature. This data was then used to propose specific RIs
that more precisely reflect the ethnic variation seen in a diverse
population of volunteers and the time of day a sample was taken.METHODS
Study Population
This study analyzed pooled data from 35 clinical trials conducted
over a period of seven years (January 2010–January 2017) at
Richmond Pharmacology, St George’s, University of London,
UK. All subjects provided written informed consent for that
specific clinical trial and all 35 trials were approved by the
Medicines and Healthcare Products Regulatory Agency
(MHRA) and a Research Ethics Committee. Additionally, all 35
trials were performed in accordance with guidelines established
by the Declaration of Helsinki and the International Conference
on Harmonisation Good Clinical Practice guidelines.
WBC count results from 13,332 venous blood samples
obtained from 7,157 healthy subjects (2,668 women and 4,489
men) who had taken part in one or more of these 35 studies were
obtained from Richmond Pharmacology’s clinical trials database.
The anonymized WBC count data from these samples and used
in this research was obtained in accordance with the Health
Research Authority and the Medical Research Council’s advice
on the use of anonymized data (Medical Research Council: data
and tissues tool kit; Health Research Authority defining research
table 2017; Health Research Authority decision tools).
All subjects were aged 18 to 76 years, nonsmokers, had not
consumed caffeine over the preceding 48 h, and their urine tested
negative for alcohol consumption and for Drugs of Abuse
(DOA). These criteria were checked for consistency with
inclusion criteria pertaining to the individual studies from
which the data was obtained.March 2020 | Volume 11 | Article 314
Coates et al. Time- and Race-Specific Haematological Reference IntervalsThe haematological results derived from samples obtained
during a screening visit prior to inclusion in a study or at the time
of admission to the clinical trial unit prior to exposure to any
study related medication (samples obtained during the screening
process, on Day -2, Day -1, or Day 1 predose). Consequently, the
results are not confounded by the effects of any IMP or non-IMP.
Number of Subjects, Blood Samples, and
Parameters
The 7,157 individual subjects whose data were used in this study
provided 13,332 blood samples. From this, a total of 76,668
individual blood parameters were available for the analysis of the
following parameters: total WBC count, neutrophils, lymphocytes,
monocytes, basophils, and eosinophils. Table 1 shows the number
of blood samples obtained per subject. The majority of subjects
(5,829) gave only one or two samples; subjects providing more
samples typically did so on account of repeat assessments (e.g., at
screening or admission) or due to participation in more than one
study over the seven-year period. The greatest number of samples
obtained was 24 samples from a single subject who had participated
in seven clinical trials during the study period.
The use of more than one sample per subject was allowed in
the methodology for the following reasons:
• It took into account normal white cell physiology and
intrasubject variation.
• It increased the number of unique blood samples available for
analysis.
• The larger sample size increases the power of the statistical
analyses, i.e., any abnormal results that were captured within
the population have a reduced confounding effect.
Where a subject gave repeated blood samples at a single time
point, an average was calculated before statistical analyses. ThisFrontiers in Pharmacology | www.frontiersin.org 3produced 74,074 blood parameters that were used for descriptive
and inferential statistical analyses.
Blood Sampling and Haematological
Analysis
Samples were obtained via venepuncture using standardized
aseptic technique by trained staff throughout the day. The
number of samples collected at each time point across the day
is shown in Table 3. Venous blood samples (4 ml) were obtained
from each subject using Vacutainer® CPT™ tubes (Beckton
Dickenson, Wokingham, UK). The tubes were placed on a
roller mixer until WBC counting took place. To maintain the
stability of the samples they were processed further within 60
min. Cell counts were carried out within 5 h after the blood was
drawn by an accredited pathology laboratory (The Doctors
Laboratory Limited, London, UK). Cells were counted
according to The Doctor’s Laboratory’s standard protocols.
Samples were centrifuged at room temperature in a horizontal
rotor for 20 min at 1,800 g. Mononuclear cells were isolated from
the whitish layer under the plasma layer, while neutrophils were
separated from the layer above the erythrocytes. Preparations were
used when purity obtained by nuclear staining (methylene-blue)
was higher than 97%. Isolated cells were immediately processed.
Statistical Analysis
The data obtained from the haematological investigations of the
subjects’ samples were grouped by their self-ascribed race into
the following groups: black (black African & black Caribbean)
and nonblack (Caucasian and Asian). Their self-ascribed “race”
was ascertained at the initial telephone recruitment stage.
Mean values and standard deviations per time of day were
calculated for each racial group for all haematological parameters.
The haematological parameters were analyzed by generalised
estimating equation (GEE) models in which race, time, and
interaction between time and race were treated as fixed effects,
age, sex, and fast status as covariates, the subject as a cluster
effect. The GEE model has a normal distribution and identity
link function with exchangeable covariance structure. The
estimated between-race differences at each time point and
within-race differences (morning vs. evening) in marginal
means from the GEE models are therefore derived and
reported together with their 95% confidence intervals. Model
parameters shown in Supplementary Table.
Reported P-values are two-sided and a P-value of <0.05 was
considered statistically significant. Adjusted normal intervals of
haematological parameters were calculated for black and
nonblack populations and for samples collected in the morning
versus samples collected in the evening. All statistical analyses
were carried out using the Statistical Analysis System (SAS)
version 9.3 (SAS Institute, Inc., Cary, NC, USA).RESULTS
Subject Characteristics
Blood samples collected from 7,157 subjects were analyzed. 926
(12.94%) of these subjects were black and 6,227 (87.06%) wereTABLE 1 | Number of blood samples per subject.
Number of Samples Number of subjects
1 4,138
2 1,691
3 613
4 294
5 164
6 85
7 65
8 31
9 28
10 20
11 8
12 5
13 3
14 4
15 1
16 1
17 2
18 1
21 1
22 1
24 1
Total 7,157March 2020 | Volume 11 | Article 314
Coates et al. Time- and Race-Specific Haematological Reference Intervalsnonblack (Table 2). A large proportion (96.1%) of the analyzed
samples were obtained from fasted subjects.
The neutrophil count represented roughly half of the total
WBC count while lymphocytes comprised about 35% of the total.
Monocytes (≈10%), eosinophils (2%–3%), and basophils (<1%)
accounted for the remainder of the WBC numbers.
Diurnal Differences in Blood Cell Counts
From 8 am to 6 pm
Diurnal variation in the total WBC and its constituent parameters
was measured at different time points for each race group and for
the total sample population (Table 3). Overall, the combined mean
WBC count for both populations (black and nonblack) was 24%
(1.40 × 109 cells/liter) higher at the end of the daily sampling period
(6 pm) relative to the morning (8 am). For black individuals, total
WBC count rose by an average of 20% from the morning until the
end of daily sampling, while the increase for nonblack volunteers
was 29% (Figure 1A). A substantial proportion of this rise can be
attributed to an overall 36% (1.08 × 109 cells/liter) increase in the
combined mean neutrophil count during the course of daily
sampling, a 34% rise for black and 44% rise for nonblack
volunteers, respectively (Figure 1B).
The combined mean lymphocyte count also rose by 16%
(0.318 × 109 cells/liter)—a 9% diurnal rise for blacks and a 16%
rise for nonblack volunteers respectively (Figure 1C).
Combined mean basophil and monocyte counts rose 3.4%
(0.001 × 109 cells/liter) (a 24% rise in black and a 3% rise in
nonblack volunteers) (Figure 1D) and 9% (0.046 × 109 cells/
liter) (a 9.6% rise in black and a 12.5% rise in nonblack
volunteers) (Figure 1E) respectively between 8 am and 6 pm.
Contrary to other parameters, the combined mean eosinophil
count showed a 30% decrease throughout the day (0.048 × 109
cells/liter)—a 52% decrease in black and a 25% decrease in
nonblack volunteers respectively (Figure 1F).
Comparison of WBC Parameters in Black
and Nonblack Subjects
Total WBC counts from black volunteers were on average lower
than those for nonblack volunteers (Table 4). Using the GEE
model analysis (Table 4), relative to nonblack volunteers, black
volunteers had a lower total WBC count across all time points
(−1.35 × 109 cells/liter, P < 0.0001) (Table 4), a lower mean
neutrophil count (−1.29 × 109 cells/liter, P < 0.0001) (Table 4), a
lower mean monocyte count (−0.86 × 108 cells/liter, P < 0.0001)Frontiers in Pharmacology | www.frontiersin.org 4(Table 4), a lower mean basophil count (−0.06 × 108 cells/liter, P <
0.0001) (Table 4), and a lower mean eosinophil count −0.15 × 108
cells/liter, P = 0.0097) (Table 4). However, black subjects had
higher mean lymphocyte counts relative to their nonblack
counterparts (0.53 × 108 cells/liter, P = 0.0082) (Table 4).
An overlap in cell count for both racial groups was observed
with respect to lymphocytes (Figure 1C) and eosinophils (Figure
1F). No overlap was observed in the case of total WBC count
(Figure 1A), neutrophils (Figure 1B), basophils (Figure 1D)
monocytes (Figure 1E).
Comparison of WBC Parameters in Samples Collected in the
Morning Versus Samples Collected in the Evening in Black and
Nonblack Subjects
WBC counts in black and nonblack subjects increased from 8
am to 6 pm. When data from both groups were pooled, the
difference was statistically significant for total WBC counts
(−1.12, P < 0.0001), neutrophil counts (−0.86, P < 0.0001),
lymphocyte counts (−2.33, P < 0.0001) and monocyte counts
(−0.34, P < 0.0001) (Table 4). The decrease in eosinophil count
during the sampling period was significant only in nonblack
subjects (0.25, P < 0.0001) (Table 4). Dirunal basophil variation
was not significantly different between 8 am and 6 pm for either
black (−0.02, P = 0.1352) or nonblack subjects (−0.01, P =
0.2083) or when both groups were combined (−0.01, P = 0.0611).
Proposed New References Intervals
Table 5 displays lower and upper normal limits of proposed new RIs
based on race (black and nonblack populations) and time of day
(morning and evening) for total WBC count and individual
parameters. For comparison, the RIs from the lab that analyzed the
samples in this study (The Doctors Laboratory) are shown inTable 6.
Table 6 also shows the RIs from a range of NHS hospitals, private
clinics and haematological charities from across the UK (available in
the public domain), which confirms that The Doctor’s Laboratory’s
RIs are consistent with those used throughout the UK and are
therefore suitable for use as comparative RIs in this manuscript.
For total WBC and neutrophils, the proposed lower limit of
normal (LLN) and upper limit of normal (ULN) of themorning and
evening ranges are lower for black volunteers, compared with
nonblack volunteers. There is little variation between both
populations with respect to lymphocyte ranges for the morning
and evening periods. The proposed morning monocyte normal
range for the black population is slightly lower than that of the
nonblack population, and evening ranges are roughly the same forTABLE 2 | Baseline characteristics of subjects.
Variable Statistics Race All
Black Nonblack
Age Number of subjects, mean age (Standard Deviation) 926,30.29(10.16) 6227,31.40(11.24) 7157,31.26(11.11)
Sex N 926 6227 7157
Female 410(44.3%) 2,258(36.2%) 2,668(37.3%)
Male 516(55.7%) 3,973(63.8%) 4,489(62.7%)
Fasted N 926 6,227 7,157
No 27(2.9%) 249(4.0%) 276(3.9%)
Yes 899(97.1%) 5,982(96.0%) 6,881(96.1%)March 2020 | Volume 11 | Article 314
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nonblack populations by time of day.
Parameter
(x108/liter)
Hour Number of subjects, mean number of cells (Standard Deviation)
Black Nonblack All
Basophils 8 30, 0.21(0.13) 426, 0.30(0.18) 456, 0.29(0.18)
9 96, 0.22(0.12) 879, 0.29(0.19) 975, 0.29(0.18)
10 141, 0.23(0.16) 1,113, 0.30(0.19) 1,254, 0.30(0.19)
11 141, 0.27(0.22) 1,006, 0.30(0.17) 1,147, 0.29(0.18)
12 206, 0.23(0.19) 1,442, 0.29(0.17) 1,648, 0.29(0.18)
13 191, 0.25(0.15) 1,394, 0.29(0.19) 1,585, 0.28(0.19)
14 192, 0.25(0.15) 1,165, 0.29(0.18) 1,357, 0.28(0.17)
15 208, 0.23(0.15) 1,297, 0.29(0.18) 1,505, 0.28(0.17)
16 294, 0.24(0.14) 1,334, 0.29(0.17) 1,628, 0.28(0.17)
17 144, 0.24(0.14) 660, 0.29(0.16) 804, 0.28(0.16)
18 85, 0.26(0.19) 270, 0.31(0.19) 355, 0.30(0.19)
Eosinophils 8 30, 2.10(1.90) 426, 2.08(1.97) 456, 2.08(1.96)
9 96, 2.21(2.66) 879, 1.81(1.35) 975, 1.85(1.53)
10 141, 1.71(2.03) 1,114, 1.87(1.89) 1255, 1.85(1.90)
11 141, 2.03(3.16) 1,006, 1.57(1.87) 1147, 1.62(2.08)
12 207, 1.58(2.06) 1,443, 1.56(1.54) 1650, 1.57(1.62)
13 191, 1.47(1.80) 1,398, 1.49(1.48) 1589, 1.49(1.52)
14 192, 1.49(1.77) 1,165, 1.52(1.50) 1357, 1.52(1.54)
15 208, 1.31(1.15) 1,300, 1.55(1.55) 1508, 1.51(1.51)
16 294, 1.33(1.29) 1,337, 1.60(1.47) 1631, 1.55(1.44)
17 145, 1.74(2.36) 664, 1.65(1.61) 809, 1.67(1.77)
18 85, 1.38(1.18) 272, 1.67(1.44) 357, 1.60(1.38)
Lymphocytes 8 31, 21.55(5.06) 426, 19.78(5.83) 457, 19.90(5.79)
9 96, 19.88(5.06) 880, 18.68(5.14) 976, 18.80(5.14)
10 142, 18.86(5.26) 1,114, 19.20(5.31) 1256, 19.16(5.30)
11 141, 19.53(5.90) 1,010, 18.53(5.04) 1151, 18.65(5.16)
12 206, 19.31(5.74) 1,444, 19.07(5.28) 1650, 19.10(5.33)
13 191, 19.57(4.91) 1,394, 19.41(5.26) 1585, 19.43(5.22)
14 192, 20.24(5.08) 1,166, 20.21(5.60) 1358, 20.22(5.53)
15 209, 20.81(5.98) 1,299, 21.00(6.01) 1508, 20.97(6.01)
16 296, 21.57(6.29) 1,338, 21.60(6.06) 1634, 21.60(6.10)
17 145, 21.85(5.51) 665, 21.76(6.01) 810, 21.78(5.92)
18 86, 23.46(6.08) 273, 22.96(6.82) 359, 23.08(6.65)
Monocytes 8 30, 4.37(1.16) 426, 5.13(1.74) 456, 5.08(1.72)
9 96, 4.62(1.85) 879, 5.08(1.72) 975, 5.04(1.74)
10 141, 4.23(1.51) 1,113, 5.23(1.81) 1,254, 5.12(1.81)
11 141, 4.35(1.67) 1,006, 4.94(1.68) 1,147, 4.87(1.69)
12 206, 4.21(1.61) 1,443, 4.98(1.70) 1,649, 4.89(1.71)
13 191, 4.33(1.37) 1,394, 5.05(1.65) 1,585, 4.96(1.64)
14 192, 4.17(1.35) 1,165, 5.16(1.62) 1,357, 5.02(1.62)
15 208, 4.29(1.39) 1,297, 5.44(1.70) 1,505, 5.28(1.71)
16 294, 4.45(1.44) 1,335, 5.48(1.62) 1,629, 5.30(1.64)
17 145, 4.73(1.61) 660, 5.54(1.68) 805, 5.40(1.69)
18 85, 4.79(1.57) 271, 5.77(1.67) 356, 5.54(1.70)
Neutrophils (x109/liter) 8 31, 2.36(0.96) 427, 3.07(1.11) 458, 3.02(1.11)
9 97, 2.34(1.00) 883, 3.30(1.20) 980, 3.20(1.22)
10 143, 2.49(0.96) 1,115, 3.55(1.30) 1,258, 3.43(1.31)
11 143, 2.45(1.11) 1,009, 3.56(1.26) 1,152, 3.42(1.30)
12 206, 2.60(1.28) 1,442, 3.73(1.38) 1,648, 3.59(1.42)
13 193, 2.78(1.19) 1,399, 3.87(1.46) 1,592, 3.74(1.47)
14 198, 2.69(1.28) 1,166, 4.09(1.50) 1,364, 3.89(1.55)
15 209, 2.89(1.26) 1,300, 4.34(1.48) 1,509, 4.14(1.53)
16 298, 2.90(1.24) 1,342, 4.49(1.49) 1,640, 4.21(1.57)
17 154, 2.87(1.11) 673, 4.40(1.52) 827, 4.12(1.57)
18 97, 3.16(1.38) 283, 4.42(1.64) 380, 4.10(1.67)
White Blood Cells (x109/liter) 8 32, 5.17(1.18) 427, 5.80(1.54) 459, 5.76(1.52)
9 98, 5.01(1.25) 886, 5.88(1.48) 984, 5.80(1.48)
10 144, 4.99(1.26) 1,126, 6.21(1.62) 1,270, 6.07(1.63)
11 147, 5.06(1.51) 1,043, 6.08(1.59) 1,190, 5.96(1.61)
12 211, 5.14(1.58) 1,477, 6.31(1.68) 1,688, 6.17(1.72)
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ULN is higher for black volunteers compared with nonblack
volunteers; little variation is seen between the evening eosinophil
ranges of both populations. Basophils morning and evening ranges
are the same for both populations.
The ULN of the evening ranges was higher for total WBC
count, neutrophils and lymphocytes when compared to theFrontiers in Pharmacology | www.frontiersin.org 6morning ranges for both populations, with the exception of
eosinophils which had a lower ULN in the evening for black
populations. The evening eosinophil range for nonblack
populations showed an increase in the LLN relative to the
morning range. No diurnal variation was seen in the ULN
ranges for both population groups with respect to monocytes
and basophils.TABLE 3 | Continued
Parameter
(x108/liter)
Hour Number of subjects, mean number of cells (Standard Deviation)
Black Nonblack All
13 196, 5.37(1.42) 1,411, 6.49(1.76) 1,607, 6.36(1.76)
14 198, 5.32(1.51) 1,169, 6.81(1.79) 1,367, 6.60(1.83)
15 209, 5.55(1.59) 1,306, 7.17(1.80) 1,515, 6.95(1.86)
16 300, 5.66(1.57) 1,349, 7.40(1.79) 1,649, 7.08(1.88)
17 155, 5.74(1.34) 681, 7.33(1.81) 836, 7.04(1.84)
18 97, 6.19(1.71) 288, 7.49(1.92) 385, 7.16(1.95)March 2020 | VFIGURE 1 | Graphs showing means of different WBC types by time and race. (A) Total WBC. (B) Neutrophils. (C) Lymphocytes. (D) Basophils. (E) Monocytes.
(F) Eosinophils.olume 11 | Article 314
Coates et al. Time- and Race-Specific Haematological Reference IntervalsTABLE 4 | Generalised estimating equation (GEE) model analysis of haematological parameters [Basophils, Eosinophils, Lymphocytes, Monocytes, Neutrophils, and
white blood cell (WBC)]: between and within group comparison.
Parameter
(x108/liter)
Comparison Hour Difference 95% CI Probability
Lower Limit Upper Limit
Basophils Blacks vs Nonblacks 8 −0.07 −0.12 −0.02 0.0038
9 −0.05 −0.07 −0.03 <0.0001
10 −0.06 −0.08 −0.04 <0.0001
11 −0.06 −0.08 −0.03 <0.0001
12 −0.07 −0.09 −0.05 <0.0001
13 −0.04 −0.06 −0.02 0.0009
14 −0.07 −0.08 −0.05 <0.0001
15 −0.07 −0.08 −0.05 <0.0001
16 −0.05 −0.07 −0.03 <0.0001
17 −0.05 −0.07 −0.03 <0.0001
18 −0.04 −0.08 −0.01 0.0127
All time points −0.06 −0.07 −0.04 <0.0001
Morning vs Evening Blacks −0.02 −0.04 0.01 0.1352
Nonblacks −0.01 −0.01 0.00 0.2083
All −0.01 −0.02 0.00 0.0611
Eosinophils Blacks vs Nonblacks 8 −0.44 −1.17 0.30 0.2430
9 −0.20 −0.42 0.02 0.0793
10 −0.19 −0.38 0.01 0.0584
11 0.11 −0.28 0.49 0.5957
12 −0.29 −0.51 −0.07 0.0110
13 −0.16 −0.37 0.05 0.1378
14 −0.04 −0.24 0.16 0.7168
15 −0.14 −0.31 0.03 0.1119
16 −0.10 −0.27 0.06 0.2220
17 0.05 −0.30 0.40 0.7815
18 −0.30 −0.55 −0.05 0.0176
All time points −0.15 −0.27 −0.04 0.0097
Morning vs Evening Blacks 0.09 −0.29 0.48 0.6289
Nonblacks 0.25 0.17 0.33 <0.0001
All 0.17 −0.02 0.36 0.0806
Lymphocytes Blacks vs Nonblacks 8 1.56 0.10 3.02 0.0367
9 0.85 −0.05 1.74 0.0629
10 0.04 −0.65 0.72 0.9207
11 1.18 0.38 1.98 0.0040
12 0.48 −0.20 1.15 0.1667
13 0.05 −0.58 0.69 0.8741
14 −0.01 −0.65 0.64 0.9809
15 0.29 −0.41 0.98 0.4203
16 0.06 −0.61 0.73 0.8576
17 0.60 −0.25 1.44 0.1658
18 0.80 −0.43 2.03 0.2021
All time points 0.53 0.14 0.93 0.0082
Morning vs Evening Blacks −2.17 −2.92 −1.41 <0.0001
Nonblacks −2.49 −2.82 −2.16 <0.0001
All −2.33 −2.74 −1.91 <0.0001
Monocytes Blacks vs Nonblacks 8 −0.85 −1.23 −0.46 <0.0001
9 −0.70 −1.00 −0.41 <0.0001
10 −0.91 −1.11 −0.70 <0.0001
11 −0.73 −0.95 −0.51 <0.0001
12 −0.74 −0.95 −0.54 <0.0001
13 −0.87 −1.06 −0.67 <0.0001
14 −0.92 −1.10 −0.75 <0.0001
15 −1.03 −1.22 −0.84 <0.0001
16 −0.98 −1.15 −0.81 <0.0001
17 −0.79 −1.06 −0.52 <0.0001
18 −0.97 −1.30 −0.65 <0.0001
All time points −0.86 −0.97 −0.75 <0.0001
Morning vs evening Blacks −0.30 −0.51 −0.08 0.0083
Nonblacks −0.39 −0.48 −0.30 <0.0001
All −0.34 −0.46 −0.22 <0.0001
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Coates et al. Time- and Race-Specific Haematological Reference IntervalsDISCUSSION
This study examined the effects of racial and diurnal variation
upon total WBC counts and counts of individual WBC
parameters (neutrophils, lymphocytes, eosinophils, basophils,
and monocytes) in 7,157 ethnically diverse individuals from
whom blood samples were obtained during the waking period
(8 am to 6 pm). This study also proposed creating separate race
and time-specific RIs for each WBC parameter. As no differenceFrontiers in Pharmacology | www.frontiersin.org 8in the number of leukocytes was observed between Caucasian
and Asian subjects, data from these two racial groups were
pooled and these volunteers are referred to as nonblack subjects.
The existing literature indicates that individuals of African
ancestry have lower WBC and neutrophil counts relative to
individuals from other ethnic backgrounds (Chen et al., 2010)
correlating with the results presented herein which demonstrated
that volunteers from African backgrounds had lower total WBC,
neutrophil, monocyte, basophil, and eosinophil counts relative toTABLE 4 | Continued
Parameter
(x108/liter)
Comparison Hour Difference 95% CI Probability
Lower Limit Upper Limit
Neutrophils (x109/liter) Blacks vs Nonblacks 8 −1.05 −1.37 −0.72 <0.0001
9 −1.07 −1.23 −0.91 <0.0001
10 −1.16 −1.32 −1.00 <0.0001
11 −1.13 −1.29 −0.97 <0.0001
12 −1.19 −1.35 −1.03 <0.0001
13 −1.16 −1.32 −0.99 <0.0001
14 −1.44 −1.62 −1.26 <0.0001
15 −1.46 −1.62 −1.29 <0.0001
16 −1.61 −1.76 −1.47 <0.0001
17 −1.52 −1.71 −1.34 <0.0001
18 −1.43 −1.69 −1.16 <0.0001
All time points −1.29 −1.38 −1.21 <0.0001
Morning vs evening Blacks −0.65 −0.80 −0.50 <0.0001
Nonblacks −1.08 −1.16 −0.99 <0.0001
All −0.86 −0.95 −0.78 <0.0001
White Blood Cells (x109/liter) Blacks vs Nonblacks 8 −1.05 −1.43 −0.67 <0.0001
9 −1.11 −1.30 −0.91 <0.0001
10 −1.29 −1.48 −1.10 <0.0001
11 −1.08 −1.29 −0.87 <0.0001
12 −1.26 −1.46 −1.07 <0.0001
13 −1.27 −1.46 −1.07 <0.0001
14 −1.52 −1.73 −1.32 <0.0001
15 −1.56 −1.76 −1.36 <0.0001
16 −1.73 −1.91 −1.55 <0.0001
17 −1.54 −1.76 −1.32 <0.0001
18 −1.48 −1.78 −1.17 <0.0001
All time points −1.35 −1.46 −1.25 <0.0001
Morning vs evening Blacks −0.91 −1.08 −0.73 <0.0001
Nonblacks −1.34 −1.43 −1.24 <0.0001
All −1.12 −1.22 −1.02 <0.0001March 2020 | Volume 11TABLE 5 | Estimated reference ranges of white blood cell (WBC), neutrophils, lymphocytes, monocytes, eosinophils, and basophils by race and time of day.
Parameter
(×109/liter)
Race Morning Evening
No. of subjects Reference range No. of subjects Reference range
WBC Black 192 2.7–7.3 437 2.9–8.7
Nonblack 1,836 3.0–9.1 2005 3.9–10.9
Neutrophils Black 191 0.6–4.2 434 0.6–5.3
Nonblack 1,832 1.0–5.8 1993 1.6–7.4
Lymphocytes Black 189 1.0–3.0 428 1.0–3.4
Nonblack 1,831 0.9–3.0 1980 1.0–3.4
Monocytes Black 189 0.1–0.7 424 0.2–0.8
Nonblack 1,831 0.2–0.9 1976 0.2–0.9
Eosinophils Black 189 0.0–0.7 425 0.0–0.6
Nonblack 1,832 0.0–0.6 1980 0.0–0.5
Basophils Black 189 0.0–0.1 424 0.0–0.1
Nonblack 1,831 0.0–0.1 1975 0.0–0.1| Article 314
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Frontiers in Pharmacology | www.frontiersin.org 9their Caucasian and Asian counterparts, but higher lymphocyte
counts. Previous research has shown that both total WBC and its
constituent cells (neutrophils, monocytes, lymphocytes,
eosinophils) fluctuate in quantity throughout the day (Sennels
et al., 2011; Pick et al., 2019). This is in line with this study’s
findings which showed that the serum levels of all cell types were
higher in the morning relative to the evening for both black and
nonblack subjects, with the exception of eosinophils which
showed the opposite trend in both groups. That is, eosinophils
were higher in the morning than in the evening. This finding was
statistically significant only for nonblack volunteers. One
possible reason why differences in basophil diurnal variation
were not significant for either black or nonblack subjects could
be because these cells make up a tiny proportion of the total
WBC count and are thus too few for any statistically significant
effects to be observed.Biological Explanations and
Consequences for the Observed Racial
Differences
Cytokine-stimulated levels of circulating neutrophils are as
numerous in people of indigenous African and Middle Eastern
races as in individuals with European ancestry, although resting
circulating neutrophil levels are lower in the former. The lower
level is not pathogenic and is termed BEN.
The allele frequency giving rise to neutropenia in some
groups of African and Middle Eastern origin has been
attributed to a selection advantage due to an associated
resistance to the development of malaria following
Plasmodium vivax infection. Individuals diagnosed with BEN
have a reduced number of bone marrow myeloid progenitors
(Rezvani et al., 2001; Hollowell et al., 2005) and lower mature
neutrophil levels (Mason et al., 1979). The change in WBC count
over the day would suggest that the likelihood of a black subject
failing to be included because of BEN is higher in the morning
than later in the day since diurnal variation would further lower
their WBC count. The mechanism of diurnal variation in
neutrophil numbers is probably not related to the endogenous
molecular clock (Ella et al., 2016; Wang et al., 2016). Neutrophils
have a high turnover rate and cortisol inhibits their apoptosis
(Zen et al., 2011). The diurnal variation seen in neutrophil count
is the inverse of that expected if glucocorticoid secretion were
responsible. Neutrophil levels are lowest when endogenous
cortisol is at its daily maximum–cortisol levels reach a peak at
around 08.30 am (Casanova-Acebes et al., 2013).
Another condition where individuals present with low
leukocyte and neutrophil counts is termed benign familial
leukopenia-neutropenia (BFLN) and has been reported in
several racial groups, including Yemenite Jews, Blacks of South
African extraction, West Indians and Arab Jordanians
(Shoenfeld et al., 1988). Individuals with BFLN were shown
not to have an increased incidence of infection, and their
response to infection did not differ from subjects who had
normal WBC (Shoenfeld et al., 1988).
Overall, mean lymphocyte counts were higher in black
subjects than in nonblack subjects. Higher lymphocyte countsTA
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Coates et al. Time- and Race-Specific Haematological Reference Intervalsin black individuals can, in some circumstances, be indicative of
infection or an autoimmune disorder. An increase in the number
of lymphocytes is also associated with certain forms of
lymphoma and leukaemia. These findings are consistent with
previously published reports (Zelzulka et al., 1987; Cheng et al.,
2004; Kaaba et al., 2004). To the contrary, some authors have
found no difference in lymphocyte count variation between racial
groups (Bain et al., 1984). A higher lymphocyte count in black
subjects may be compensating for a lower neutrophil count and
this phenomenon should be addressed in future research where
prospective samples are analyzed.
Potential Advantages of Using Race and
Time-Specific RIs
The variations seen in the present study together with the
recognised physiological differences between racial
subpopulations and acknowledged racial differences in RIs
for various haematological tests (Ash et al., 1983; Bain, 1996)
show that for a multiracial country with a diverse population
such as the United Kingdom, it is important to establish race-
specific RIs. RIs developed using a mainly Caucasian
population (Aytekin and Emerk, 2008; Lim et al., 2015) that
fail to consider racial and diurnal variation, arguably lack
validity and could result in clinicians being misled about any
potential drug effects as well as the status of an individual’s
immune system, resulting in their inappropriate exclusion
from a clinical trial. It is thus more appropriate to establish
ranges that take into account an individual ’s racial
background and the time of day. It is important to highlight
that, in this study, the confidence intervals of the mean WBC
counts did not overlap at any point throughout the day,
indicating that black and nonblack populations have
completely separate WBC distributions.
In comparison with The Doctors Laboratory (TDL)
reference range that covers a wider population, the proposed
intervals are generally narrower and the upper and lower
limits of normal have, for most parameters, shifted. They,
now, more accurately represent the normal ranges observed in
a healthy racially diverse population.
The proposed RIs herein may impact clinical trials in several
ways. Firstly, they may facilitate better representation of black
racial groups in healthy volunteer trials. In the suggested RIs,
the total WBC and neutrophil LLN for black subjects is lower
than that of TDL, which may ensure that black subjects with a
low neutrophil count normal for their racial group are not
unnecessarily excluded from trials. Secondly, it may ensure that
the recruitment of subjects into healthy volunteer trials is more
representative of the local population. The ULN for total WBC
and neutrophil counts in black subjects is also lower than in
TDLs reference range. Therefore, a black subject with a
morning WBC count of 10.0 × 109/liter may currently be
enrolled in a trial as this value is within the TDL reference
range despite the value being 33% higher than the morning
ULN normal for their race. Thus, the proposed RIs may allow
better identification of subjects that should not be included in aFrontiers in Pharmacology | www.frontiersin.org 10healthy volunteer trial, at least until further clinical assessments
have been conducted. Thirdly, more specific RIs may aid the
development of rules governing postdose changes in WBC
parameters. For example, an IMP that is expected to affect
haematological parameters may require specific trial stopping
rules concerning WBC counts. The race and time-specific RIs
are generally narrower than TDL’s RIs, which could facilitate
more accurate intra-subject monitoring of postdose changes.
This offers several advantages for participant safety (e.g.,
quicker identification of drug-induced abnormalities and
more accurate rules on when dosing cessation should be
triggered) and ensures that trials are not stopped prematurely
because values fall outside RIs that do not accommodate race or
time of day. Fourthly, time-specific RIs may allow for greater
attention being paid to the timing of blood samples being taken
during clinical trials and enhanced comparability of results.
Screening or admission blood tests may be taken at any time
during the day, whereas postdose samples, like most clinical
procedures after dosing, are often scheduled at a specific time
and taken early in the morning. Often the untimed, predose
samples are used as a baseline. Ensuring baseline and on-study
haematology samples are collected at matching time points will
aid better data interpretation and reporting.
Overall, the main benefit of race- and time-specific RIs is to
facilitate accurate testing of drugs in development across a
diverse population of healthy subjects and enable more precise
postdose safety monitoring and reporting of clinical trials.
Limitations of This Research
Limitations of this work included unbalanced subject
demographics weighing towards white and Asian males, and
sample collection between 8 am–6 pm that limited the analysis
period to waking hours. It is likely that, in this analysis, the peak
number of WBC counts was missed because diurnal peaks of
various populations of WBCs may occur after 6 pm, as
previously documented: eosinophils and basophils peak
around midnight (12 am to 4 am) (Uhrbrand, 1958; Boseila,
1959; Dahl, 1977); monocyte counts peak at 8 pm (Haus et al.,
1983), and neutrophils between 4 pm to 8 pm (Haus et al.,
1983). However, trial participants are typically not screened for
inclusion in study trials during these time periods.
Nevertheless, this study was high-powered: it analyzed 13,332
blood samples from 7,157 healthy volunteers, adding significant
weight to the body of evidence which indicates that WBC count
parameters within healthy trial volunteers vary by time of day
and race
Furthermore, blood samples were grouped according to the
volunteers’ self-ascribed racial groups. As ascription of race is
acknowledged as a poor marker for genetic diversity
(Takezawa et al., 2014; Duster, 2015), it would be preferable
but possibly impractical to group subjects according to the
Duffy antigen allele they possess at the time of recruitment.
Lastly, the authors of this report are aware that the RIs
proposed herein do not account for the differences in number
of study subjects by ethnic group.March 2020 | Volume 11 | Article 314
Coates et al. Time- and Race-Specific Haematological Reference IntervalsOther Factors and Scope for Future Work
In addition to racial and diurnal variation in WBC parameters,
the literature indicates that age, gender, smoking status (Hsieh
et al., 2007), poor sleep and BMI (Nishitani and Dakakibara,
2007) may also affect neutrophil and total WBC counts. These
factors should be taken into account for any prospective future
studies investigating diurnal and racial differences in
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